{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:39:30Z","timestamp":1791095970447,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,10,12]],"date-time":"2010-10-12T00:00:00Z","timestamp":1286841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,10,12]],"date-time":"2010-10-12T00:00:00Z","timestamp":1286841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1038\/nrmicro2437","type":"journal-article","created":{"date-parts":[[2010,10,12]],"date-time":"2010-10-12T09:32:59Z","timestamp":1286875979000},"page":"827-834","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Nanobead-based interventions for the treatment and prevention of tuberculosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Gareth","family":"Griffiths","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj B.","family":"Sable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal K.","family":"Khuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,12]]},"reference":[{"key":"BFnrmicro2437_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1172\/JCI34614","volume":"118","author":"D Young","year":"2008","unstructured":"Young, D., Perkins, M., Duncan, K. & Barry, C. E. 3rd. Confronting the scientific obstacles to global control of tuberculosis. J. Clin. Invest. 118, 1255\u20131265 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnrmicro2437_CR2","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.1185449","volume":"328","author":"C Dye","year":"2010","unstructured":"Dye, C. & Williams, B. G. The population dynamics and control of tuberculosis. Science 328, 856\u2013861 (2010).","journal-title":"Science"},{"key":"BFnrmicro2437_CR3","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1126\/science.1184784","volume":"328","author":"DG Russell","year":"2010","unstructured":"Russell, D. G., Barry, C. E. 3rd & Flynn, J. L. Tuberculosis: what we don't know can, and does, hurt us. Science 328, 852\u2013856 (2010).","journal-title":"Science"},{"key":"BFnrmicro2437_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/QCO.0b013e328319bce6","volume":"21","author":"ED Chan","year":"2008","unstructured":"Chan, E. D. & Iseman, M. D. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr. Opin. Infect. Dis. 21, 587\u2013595 (2008).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"BFnrmicro2437_CR5","first-page":"1320","volume":"13","author":"Y Zhang","year":"2009","unstructured":"Zhang, Y. & Yew, W. W. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 13, 1320\u20131330 (2009).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"BFnrmicro2437_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrmicro2048","volume":"7","author":"C Dye","year":"2009","unstructured":"Dye, C. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nature Rev. Microbiol. 7, 81\u201387 (2009).","journal-title":"Nature Rev. Microbiol."},{"key":"BFnrmicro2437_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10875-007-9084-0","volume":"27","author":"K Bhatt","year":"2007","unstructured":"Bhatt, K. & Salgame, P. Host innate immune response to Mycobacterium tuberculosis. J. Clin. Immunol. 27, 347\u2013362 (2007).","journal-title":"J. Clin. Immunol."},{"key":"BFnrmicro2437_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.cellbio.20.010403.114015","volume":"20","author":"I Vergne","year":"2004","unstructured":"Vergne, I., Chua, J., Singh, S. B. & Deretic, V. Cell biology of Mycobacterium tuberculosis phagosome. Annu. Rev. Cell Dev. Biol. 20, 367\u2013394 (2004).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"BFnrmicro2437_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","volume":"27","author":"AM Cooper","year":"2009","unstructured":"Cooper, A. M. Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 27, 393\u2013422 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrmicro2437_CR10","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s11095-006-0284-8","volume":"23","author":"P Couvreur","year":"2006","unstructured":"Couvreur, P. & Vauthier, C. Nanotechnology: intelligent design to treat complex disease. Pharm. Res. 23, 1417\u20131450 (2006).","journal-title":"Pharm. Res."},{"key":"BFnrmicro2437_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","volume":"83","author":"L Zhang","year":"2008","unstructured":"Zhang, L. et al. Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 83, 761\u2013769 (2008).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BFnrmicro2437_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd2614","volume":"7","author":"ME Davis","year":"2008","unstructured":"Davis, M. E., Chen, Z. G. & Shin, D. M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature Rev. Drug Discov. 7, 771\u2013782 (2008).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrmicro2437_CR13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.addr.2009.11.023","volume":"62","author":"A Sosnik","year":"2010","unstructured":"Sosnik, A., Carcaboso, A. M., Glisoni, R. J., Moretton, M. A. & Chiappetta, D. A. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery. Adv. Drug Deliv. Rev. 62, 547\u2013559 (2010).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnrmicro2437_CR14","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.2174\/1381612043383250","volume":"10","author":"GK Khuller","year":"2004","unstructured":"Khuller, G. K., Kapur, M. & Sharma, S. Liposome technology for drug delivery against mycobacterial infections. Curr. Pharm. Des 10, 3263\u20133274 (2004).","journal-title":"Curr. Pharm. Des"},{"key":"BFnrmicro2437_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.tube.2004.11.003","volume":"85","author":"R Pandey","year":"2005","unstructured":"Pandey, R. & Khuller, G. K. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis 85, 227\u2013234 (2005).","journal-title":"Tuberculosis"},{"key":"BFnrmicro2437_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0955-0674(03)00083-8","volume":"15","author":"M Desjardins","year":"2003","unstructured":"Desjardins, M. & Griffiths, G. Phagocytosis: latex leads the way. Curr. Opin. Cell Biol. 15, 498\u2013503 (2003).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnrmicro2437_CR17","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/j.1462-5822.2009.01326.x","volume":"11","author":"T Areschoug","year":"2009","unstructured":"Areschoug, T. & Gordon, S. Scavenger receptors: role in innate immunity and microbial pathogenesis. Cell. Microbiol. 11, 1160\u20131169 (2009).","journal-title":"Cell. Microbiol."},{"key":"BFnrmicro2437_CR18","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/j.micinf.2006.06.004","volume":"8","author":"A Yoshida","year":"2006","unstructured":"Yoshida, A. et al. Selective delivery of rifampicin incorporated into poly(DL-lactic-co-glycolic) acid microspheres after phagocytotic uptake by alveolar macrophages, and the killing effect against intracellular Mycobacterium bovis Calmette\u2013Gu\u00e9rin. Microbes Infect. 8, 2481\u20132491 (2006).","journal-title":"Microbes Infect."},{"key":"BFnrmicro2437_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jconrel.2009.11.020","volume":"142","author":"K Hirota","year":"2010","unstructured":"Hirota, K. et al. Delivery of rifampicin\u2013PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis. J. Control. Release 142, 339\u2013346 (2010).","journal-title":"J. Control. Release"},{"key":"BFnrmicro2437_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijpharm.2007.05.062","volume":"345","author":"KO Kisich","year":"2007","unstructured":"Kisich, K. O. et al. Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis. Int. J. Pharm. 345, 154\u2013162 (2007).","journal-title":"Int. J. Pharm."},{"key":"BFnrmicro2437_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.colsurfb.2009.10.036","volume":"76","author":"T Onoshita","year":"2010","unstructured":"Onoshita, T. et al. The behavior of PLGA microspheres containing rifampicin in alveolar macrophages. Colloids Surf. B Biointerfaces 76, 151\u2013157 (2010).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"BFnrmicro2437_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2174\/1567201043334669","volume":"1","author":"R Pandey","year":"2004","unstructured":"Pandey, R. & Khuller, G. K. Polymer based drug delivery systems for mycobacterial infections. Curr. Drug Deliv. 1, 195\u2013201 (2004).","journal-title":"Curr. Drug Deliv."},{"key":"BFnrmicro2437_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","volume":"28","author":"MS Shive","year":"1997","unstructured":"Shive, M. S. & Anderson, J. M. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28, 5\u201324 (1997).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnrmicro2437_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1023\/A:1010061013365","volume":"2","author":"YV Anisimova","year":"2000","unstructured":"Anisimova, Y. V., Gelperina, S. I., Peloquin, C. A. & Heifets, L. B. Nanoparticles as antituberculosis drugs carriers: effect on activity against Mycobacterium tuberculosis in human monocyte-derived macrophages. J. Nanopart. Res. 2, 165\u2013171 (2000).","journal-title":"J. Nanopart. Res."},{"key":"BFnrmicro2437_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejps.2007.06.006","volume":"32","author":"P Muttil","year":"2007","unstructured":"Muttil, P. et al. Inhalable microparticles containing large payload of anti-tuberculosis drugs. Eur. J. Pharm. Sci. 32, 140\u2013150 (2007).","journal-title":"Eur. J. Pharm. Sci."},{"key":"BFnrmicro2437_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","volume":"86","author":"R Singh","year":"2009","unstructured":"Singh, R. & Lillard, J. W. Jr. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol. 86, 215\u2013223 (2009).","journal-title":"Exp. Mol. Pathol."},{"key":"BFnrmicro2437_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/jac\/dkh411","volume":"54","author":"A Sharma","year":"2004","unstructured":"Sharma, A., Sharma, S. & Khuller, G. K. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral\/aerosolized antitubercular drug carriers for treatment of tuberculosis. J. Antimicrob. Chemother. 54, 761\u2013766 (2004).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnrmicro2437_CR28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/jac\/dkg477","volume":"52","author":"R Pandey","year":"2003","unstructured":"Pandey, R. et al. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J. Antimicrob. Chemother. 52, 981\u2013986 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnrmicro2437_CR29","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1128\/AAC.01164-06","volume":"51","author":"L Garcia-Contreras","year":"2007","unstructured":"Garcia-Contreras, L. et al. Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model. Antimicrob. Agents Chemother. 51, 2830\u20132836 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro2437_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1574-6968.2006.00224.x","volume":"258","author":"Z Ahmad","year":"2006","unstructured":"Ahmad, Z., Sharma, S. & Khuller, G. K. The potential of azole antifungals against latent\/persistent tuberculosis. FEMS Microbiol. Lett. 258, 200\u2013203 (2006).","journal-title":"FEMS Microbiol. Lett."},{"key":"BFnrmicro2437_CR31","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1159\/000110009","volume":"53","author":"R Pandey","year":"2007","unstructured":"Pandey, R. & Khuller, G. K. Nanoparticle-based oral drug delivery system for an injectable antibiotic \u2013 streptomycin. Evaluation in a murine tuberculosis model. Chemotherapy 53, 437\u2013441 (2007).","journal-title":"Chemotherapy"},{"key":"BFnrmicro2437_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0169-409X(01)00152-1","volume":"50","author":"N Hussain","year":"2001","unstructured":"Hussain, N., Jaitley, V. & Florence, A. T. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv. Drug Deliv. Rev. 50, 107\u2013142 (2001).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnrmicro2437_CR33","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1517\/17425240802600662","volume":"5","author":"Z Ahmad","year":"2008","unstructured":"Ahmad, Z. & Khuller, G. K. Alginate-based sustained release drug delivery systems for tuberculosis. Expert Opin. Drug Deliv. 5, 1323\u20131334 (2008).","journal-title":"Expert Opin. Drug Deliv."},{"key":"BFnrmicro2437_CR34","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/S0142-9612(00)00115-0","volume":"21","author":"RA Jain","year":"2000","unstructured":"Jain, R. A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21, 2475\u20132490 (2000).","journal-title":"Biomaterials"},{"key":"BFnrmicro2437_CR35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ejps.2008.11.015","volume":"36","author":"M Gaumet","year":"2009","unstructured":"Gaumet, M., Gurny, R. & Delie, F. Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size. Eur. J. Pharm. Sci. 36, 465\u2013473 (2009).","journal-title":"Eur. J. Pharm. Sci."},{"key":"BFnrmicro2437_CR36","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrmicro1419","volume":"4","author":"YA Skeiky","year":"2006","unstructured":"Skeiky, Y. A. & Sadoff, J. C. Advances in tuberculosis vaccine strategies. Nature Rev. Microbiol. 4, 469\u2013476 (2006).","journal-title":"Nature Rev. Microbiol."},{"key":"BFnrmicro2437_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.tim.2006.11.008","volume":"15","author":"P Andersen","year":"2007","unstructured":"Andersen, P. Vaccine strategies against latent tuberculosis infection. Trends Microbiol. 15, 7\u201313 (2007).","journal-title":"Trends Microbiol."},{"key":"BFnrmicro2437_CR38","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.4049\/jimmunol.173.5.3148","volume":"173","author":"T Fifis","year":"2004","unstructured":"Fifis, T. et al. Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. J. Immunol. 173, 3148\u20133154 (2004).","journal-title":"J. Immunol."},{"key":"BFnrmicro2437_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymeth.2006.05.016","volume":"40","author":"SD Xiang","year":"2006","unstructured":"Xiang, S. D. et al. Pathogen recognition and development of particulate vaccines: does size matter? Methods 40, 1\u20139 (2006).","journal-title":"Methods"},{"key":"BFnrmicro2437_CR40","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1021\/nl071542i","volume":"7","author":"Y Hu","year":"2007","unstructured":"Hu, Y. et al. Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. Nano Lett. 7, 3056\u20133064 (2007).","journal-title":"Nano Lett."},{"key":"BFnrmicro2437_CR41","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nmat2202","volume":"7","author":"A Verma","year":"2008","unstructured":"Verma, A. et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nature Mater. 7, 588\u2013595 (2008).","journal-title":"Nature Mater."},{"key":"BFnrmicro2437_CR42","first-page":"19","volume":"21","author":"N Dhiman","year":"1998","unstructured":"Dhiman, N. & Khuller, G. K. Protective efficacy of mycobacterial 71-kDa cell wall associated protein using poly (DL-lactide-co-glycolide) microparticles as carrier vehicles. FEMS Immunol. Med. Microbiol. 21, 19\u201328 (1998).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"BFnrmicro2437_CR43","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/S0264-410X(98)00372-7","volume":"17","author":"N Venkataprasad","year":"1999","unstructured":"Venkataprasad, N. et al. Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers. Vaccine 17, 1814\u20131819 (1999).","journal-title":"Vaccine"},{"key":"BFnrmicro2437_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jconrel.2005.01.014","volume":"104","author":"ZK Carpenter","year":"2005","unstructured":"Carpenter, Z. K., Williamson, E. D. & Eyles, J. E. Mucosal delivery of microparticle encapsulated ESAT-6 induces robust cell-mediated responses in the lung milieu. J. Control. Release 104, 67\u201377 (2005).","journal-title":"J. Control. Release"},{"key":"BFnrmicro2437_CR45","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/10611860801900462","volume":"16","author":"DJ Kirby","year":"2008","unstructured":"Kirby, D. J. et al. PLGA microspheres for the delivery of a novel subunit TB vaccine. J. Drug Target 16, 282\u2013293 (2008).","journal-title":"J. Drug Target"},{"key":"BFnrmicro2437_CR46","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s11095-009-0028-7","volume":"27","author":"S Shi","year":"2010","unstructured":"Shi, S. & Hickey, A. J. PLGA microparticles in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen TB10.4-Ag85B. Pharm. Res. 27, 350\u2013360 (2010).","journal-title":"Pharm. Res."},{"key":"BFnrmicro2437_CR47","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1208\/s12248-010-9193-1","volume":"12","author":"D Lu","year":"2010","unstructured":"Lu, D. et al. Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity. AAPS J. 12, 338\u2013347 (2010).","journal-title":"AAPS J."},{"key":"BFnrmicro2437_CR48","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/s11095-009-9957-4","volume":"26","author":"P Muttil","year":"2009","unstructured":"Muttil, P., Wang, C. & Hickey, A. J. Inhaled drug delivery for tuberculosis therapy. Pharm. Res. 26, 2401\u20132416 (2009).","journal-title":"Pharm. Res."},{"key":"BFnrmicro2437_CR49","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1016\/j.vaccine.2004.05.005","volume":"22","author":"HJ Mollenkopf","year":"2004","unstructured":"Mollenkopf, H. J. et al. Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles. Vaccine 22, 2690\u20132695 (2004).","journal-title":"Vaccine"},{"key":"BFnrmicro2437_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0165-2478(03)00176-7","volume":"90","author":"P Johansen","year":"2003","unstructured":"Johansen, P. et al. Anti-mycobacterial immunity induced by a single injection of M. leprae Hsp65-encoding plasmid DNA in biodegradable microparticles. Immunol. Lett. 90, 81\u201385 (2003).","journal-title":"Immunol. Lett."},{"key":"BFnrmicro2437_CR51","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.vaccine.2003.09.044","volume":"22","author":"M Bivas-Benita","year":"2004","unstructured":"Bivas-Benita, M. et al. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis. Vaccine 22, 1609\u20131615 (2004).","journal-title":"Vaccine"},{"key":"BFnrmicro2437_CR52","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1016\/j.vaccine.2009.04.033","volume":"27","author":"M Bivas-Benita","year":"2009","unstructured":"Bivas-Benita, M. et al. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA\u2013PEI nanoparticles enhances T cell responses in a DNA prime\/protein boost vaccination regimen in mice. Vaccine 27, 4010\u20134017 (2009).","journal-title":"Vaccine"},{"key":"BFnrmicro2437_CR53","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nnano.2007.149","volume":"2","author":"D Akin","year":"2007","unstructured":"Akin, D. et al. Bacteria-mediated delivery of nanoparticles and cargo into cells. Nature Nanotech. 2, 441\u2013449 (2007).","journal-title":"Nature Nanotech."},{"key":"BFnrmicro2437_CR54","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1086\/593175","volume":"198","author":"CL Cosma","year":"2008","unstructured":"Cosma, C. L., Humbert, O., Sherman, D. R. & Ramakrishnan, L. Trafficking of superinfecting Mycobacterium organisms into established granulomas occurs in mammals and is independent of the Erp and ESX-1 mycobacterial virulence loci. J. Infect. Dis. 198, 1851\u20131855 (2008).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro2437_CR55","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1073\/pnas.0800043105","volume":"105","author":"L Garcia-Contreras","year":"2008","unstructured":"Garcia-Contreras, L. et al. Immunization by a bacterial aerosol. Proc. Natl Acad. Sci. USA 105, 4656\u20134660 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2437_CR56","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1016\/j.vaccine.2007.03.039","volume":"25","author":"S Ajdary","year":"2007","unstructured":"Ajdary, S. et al. Oral administration of BCG encapsulated in alginate microspheres induces strong TH1 response in BALB\/c mice. Vaccine 25, 4595\u20134601 (2007).","journal-title":"Vaccine"},{"key":"BFnrmicro2437_CR57","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1073\/pnas.0611430104","volume":"104","author":"YL Wong","year":"2007","unstructured":"Wong, Y. L. et al. Drying a tuberculosis vaccine without freezing. Proc. Natl Acad. Sci. USA 104, 2591\u20132595 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2437_CR58","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tibtech.2007.09.005","volume":"25","author":"JC Sung","year":"2007","unstructured":"Sung, J. C., Pulliam, B. L. & Edwards, D. A. Nanoparticles for drug delivery to the lungs. Trends Biotechnol. 25, 563\u2013570 (2007).","journal-title":"Trends Biotechnol."},{"key":"BFnrmicro2437_CR59","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.tibtech.2009.01.003","volume":"27","author":"R Singh","year":"2009","unstructured":"Singh, R. & Kostarelos, K. Designer adenoviruses for nanomedicine and nanodiagnostics. Trends Biotechnol. 27, 220\u2013229 (2009).","journal-title":"Trends Biotechnol."},{"key":"BFnrmicro2437_CR60","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.it.2006.10.005","volume":"27","author":"ST Reddy","year":"2006","unstructured":"Reddy, S. T., Swartz, M. A. & Hubbell, J. A. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol. 27, 573\u2013579 (2006).","journal-title":"Trends Immunol."},{"key":"BFnrmicro2437_CR61","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1126\/science.1123933","volume":"311","author":"PT Liu","year":"2006","unstructured":"Liu, P. T. et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770\u20131773 (2006).","journal-title":"Science"},{"key":"BFnrmicro2437_CR62","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.4049\/jimmunol.179.4.2060","volume":"179","author":"PT Liu","year":"2007","unstructured":"Liu, P. T., Stenger, S., Tang, D. H. & Modlin, R. L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 179, 2060\u20132063 (2007).","journal-title":"J. Immunol."},{"key":"BFnrmicro2437_CR63","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1034\/j.1399-3003.2000.16a20.x","volume":"16","author":"S Sharma","year":"2000","unstructured":"Sharma, S., Verma, I. & Khuller, G. K. Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study. Eur. Respir. J. 16, 112\u2013117 (2000).","journal-title":"Eur. Respir. J."},{"key":"BFnrmicro2437_CR64","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.micinf.2006.02.030","volume":"8","author":"JC Toro","year":"2006","unstructured":"Toro, J. C. et al. Enhanced susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype. Microbes Infect. 8, 1985\u20131993 (2006).","journal-title":"Microbes Infect."},{"key":"BFnrmicro2437_CR65","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/3906","volume":"4","author":"EC Bottger","year":"1998","unstructured":"Bottger, E. C., Springer, B., Pletschette, M. & Sander, P. Fitness of antibiotic-resistant microorganisms and compensatory mutations. Nature Med. 4, 1343\u20131344 (1998).","journal-title":"Nature Med."},{"key":"BFnrmicro2437_CR66","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/187152607782110022","volume":"7","author":"L Amaral","year":"2007","unstructured":"Amaral, L., Martins, M. & Viveiros, M. Phenothiazines as anti-multi-drug resistant tubercular agents. Infect. Disord. Drug Targets 7, 257\u2013265 (2007).","journal-title":"Infect. Disord. Drug Targets"},{"key":"BFnrmicro2437_CR67","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nature06345","volume":"450","author":"C Kuijl","year":"2007","unstructured":"Kuijl, C. et al. Intracellular bacterial growth is controlled by a kinase network around PKB\/AKT1. Nature 450, 725\u2013730 (2007).","journal-title":"Nature"},{"key":"BFnrmicro2437_CR68","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/nbt1171","volume":"23","author":"CC Lee","year":"2005","unstructured":"Lee, C. C., MacKay, J. A., Frechet, J. M. & Szoka, F. C. Designing dendrimers for biological applications. Nature Biotechnol. 23, 1517\u20131526 (2005).","journal-title":"Nature Biotechnol."},{"key":"BFnrmicro2437_CR69","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/156720107779314794","volume":"4","author":"PV Kumar","year":"2007","unstructured":"Kumar, P. V., Agashe, H., Dutta, T. & Jain, N. K. PEGylated dendritic architecture for development of a prolonged drug delivery system for an antitubercular drug. Curr. Drug Deliv. 4, 11\u201319 (2007).","journal-title":"Curr. Drug Deliv."},{"key":"BFnrmicro2437_CR70","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1084\/jem.20071367","volume":"205","author":"AJ Wolf","year":"2008","unstructured":"Wolf, A. J. et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 205, 105\u2013115 (2008).","journal-title":"J. Exp. Med."}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrmicro2437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrmicro2437","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrmicro2437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:31:05Z","timestamp":1684863065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrmicro2437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,12]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["BFnrmicro2437"],"URL":"https:\/\/doi.org\/10.1038\/nrmicro2437","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,12]]},"assertion":[{"value":"12 October 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}